Wellgistics Health (NASDAQ:WGRX) Stock Rating Lowered by Wall Street Zen

Wall Street Zen cut shares of Wellgistics Health (NASDAQ:WGRXFree Report) from a hold rating to a sell rating in a research report report published on Saturday morning.

Wellgistics Health Price Performance

Shares of NASDAQ WGRX opened at $1.37 on Friday. The company has a quick ratio of 0.11, a current ratio of 0.32 and a debt-to-equity ratio of 11.16. The stock’s 50-day simple moving average is $1.05. Wellgistics Health has a 12 month low of $0.62 and a 12 month high of $7.04.

Wellgistics Health (NASDAQ:WGRXGet Free Report) last announced its earnings results on Tuesday, August 19th. The company reported ($0.11) earnings per share (EPS) for the quarter. The business had revenue of $7.79 million for the quarter.

Wellgistics Health Company Profile

(Get Free Report)

Founded in 2022, Wellgistics Health is a holding company for various existing and planned strategic businesses centered around pharmaceuticals and healthcare services. As a micro health ecosystem, our portfolio of companies consists of a pharmacy, wholesale operations, and a technology division with a novel platform for hub and clinical services.

See Also

Receive News & Ratings for Wellgistics Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Wellgistics Health and related companies with MarketBeat.com's FREE daily email newsletter.